Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic plc    MDT   IE00BTN1Y115


Delayed Quote. Delayed Nyse - 01/22 04:10:00 pm
116.58 USD   -1.13%
01/20Quarterly Report I 20/21
01/19Zimmer Biomet Appoints Chief Transformation Officer
01/15MEDTRONIC : NANS 2021 Neuromodulation Investor Briefing
Business Summary
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows:

- general and minimally invasive surgery (28.9%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;

- vascular diseases and cardiac surgery (18.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;

- cardiac rhythm management (17.8%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;

- neurological disorders (10.1%): neurostimulation and pumped medication administration products, diagnostic tools, etc.;

- spinal disorders (8.7%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;

- diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps;

- other (7.9%).

Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.6%) and other (48.1%).

Number of employees : 90 000 people.
Sales per Business
USD (in Million)%USD (in Million)%
Cardiac and Vascular11,50537.7%10,46836.2% -9.01%
Minimally Invasive Therapies8,47827.7%8,35228.9% -1.49%
Restorative Therapies8,18326.8%7,72526.7% -5.6%
Diabetes2,3917.8%2,3688.2% -0.96%
Sales per region
USD (in Million)%
United States14,91951.6%
Non - United States Developed Markets9,20231.8%
Emerging Markets4,70716.3%
Rest of the World--
Managers and Directors
Geoffrey Martha502020Chairman & Chief Executive Officer
Mark Ploof-2016Senior VP-Global Operations & Business Services
Karen L. Parkhill55-Chief Financial Officer & Executive Vice President
Richard E. Kuntz, Dr.642015Senior VP, Chief Scientific & Clinical Officer
Richard Anderson652017Independent Director
Craig Arnold602015Independent Director
Scott Donnelly582017Lead Independent Director
Randall Hogan642015Independent Director
Michael O. Leavitt692011Independent Director
James T. Lenehan712007Independent Director
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,346,019,949 1,345,233,617 99.9% 0 0.0% 99.9%
The Vanguard Group, Inc. 105,905,599 7.87%
Capital Research & Management Co. 100,591,200 7.47%
SSgA Funds Management, Inc. 57,994,497 4.31%
Massachusetts Financial Services Co. 50,534,429 3.75%
Wellington Management Co. LLP 44,424,257 3.30%
BlackRock Fund Advisors 32,885,742 2.44%
Lazard Asset Management LLC 24,294,565 1.80%
Geode Capital Management LLC 20,629,578 1.53%
T. Rowe Price Associates, Inc. (Investment Management) 17,659,809 1.31%
Northern Trust Investments, Inc.(Investment Management) 16,291,188 1.21%
Itamar Medical Ltd. (ITMR) 40,307,4139.52%26,814,506 USD
Markets and indexes
- Main Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  MDT:US
- Reuters Code :  MDT.N
- Datastream Code :  
Company contact information
Medtronic plc
Ground Floor, Block 3090-3094, Citywest Business Campus Lake Drive
IE-D24 Dublin, Leinster

Phone : +353 1 511 1400
Fax : +353 0 1807 7220
web site : http://newsroom.medtronic.com/investor-overview/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Medtronic plc
Sector Medical Equipment, Supplies & Distribution - NEC